Therapeutic versus prophylactic anticoagulation for severe COVID-19: A randomized phase II clinical trial (HESACOVID)

INTRODUCTION: Coronavirus disease 2019 (COVID-19) causes a hypercoagulable state. Several autopsy studies have found microthrombi in pulmonary circulation. METHODS: In this randomized, open-label, phase II study, we randomized COVID-19 patients requiring mechanical ventilation to receive either ther...

Descripción completa

Detalles Bibliográficos
Autores principales: Lemos, Anna Cristina Bertoldi, do Espírito Santo, Douglas Alexandre, Salvetti, Maísa Cabetti, Gilio, Renato Noffs, Agra, Lucas Barbosa, Pazin-Filho, Antonio, Miranda, Carlos Henrique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Full Length Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7503069/
https://www.ncbi.nlm.nih.gov/pubmed/32977137
http://dx.doi.org/10.1016/j.thromres.2020.09.026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7503069/
https://www.ncbi.nlm.nih.gov/pubmed/32977137
http://dx.doi.org/10.1016/j.thromres.2020.09.026

Ejemplares similares